Document is current
Any future updates will be listed below
-
Authors
Pratley, Richard E https://orcid.org/0000-0002-2912-1389
Jacob, Stephan
Baek, Seungjae
Trautmann, Michael E
Hompesch, Marcus https://orcid.org/0000-0001-5867-2131
Han, OakPil
Stewart, John
Sorli, Christopher H
Shaunik, Alka
Yoon, Kun-Ho
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02075281 at ClinicalTrials.govnct02075281 at ClinicalTrials.govDocuments that mention this clinical trial
Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline
https://doi.org/10.1136/bmjdrc-2021-002207
53-OR: Efficacy of Efpeglenatide in Patients with Obesity and Prediabetes: A Subanalysis of the BALANCE 205 Study
https://doi.org/10.2337/db19-53-or
1001-P: Effects of Efpeglenatide on Body Weight, BMI, and Waist Circumference in Patients With Obesity Without Diabetes Stratified by Baseline Characteristics: A Subanalysis of BALANCE 205
https://doi.org/10.2337/db19-1001-p
nct02075281 at ClinicalTrials.govDocuments that mention this clinical trial
Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline
https://doi.org/10.1136/bmjdrc-2021-002207
53-OR: Efficacy of Efpeglenatide in Patients with Obesity and Prediabetes: A Subanalysis of the BALANCE 205 Study
https://doi.org/10.2337/db19-53-or
1001-P: Effects of Efpeglenatide on Body Weight, BMI, and Waist Circumference in Patients With Obesity Without Diabetes Stratified by Baseline Characteristics: A Subanalysis of BALANCE 205
https://doi.org/10.2337/db19-1001-p
Documents that mention this clinical trial
Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline
https://doi.org/10.1136/bmjdrc-2021-002207
53-OR: Efficacy of Efpeglenatide in Patients with Obesity and Prediabetes: A Subanalysis of the BALANCE 205 Study
https://doi.org/10.2337/db19-53-or
1001-P: Effects of Efpeglenatide on Body Weight, BMI, and Waist Circumference in Patients With Obesity Without Diabetes Stratified by Baseline Characteristics: A Subanalysis of BALANCE 205
https://doi.org/10.2337/db19-1001-p
-
Funding
Funding for this research was provided by:
Hanmi Pharmaceuticals (N/A)
Sanofi (N/A)
- License Information
